P.N. Gerolymatos S.A.
Records under this name other than patents P.N. Gerolymatos S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to P.N. Gerolymatos S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,030,136 | Use of phanquinone for the treatment or prevention of memory impairment Formerly held Lapsed on the fee record Ended Apr 18, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 18, 2014 | USPTO record |
| US 7,629,354 | Use of phanquinone for the treatment of Alzheimer's disease Formerly held Lapsed on the fee record Ended Dec 8, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 8, 2013 | USPTO record |
| US 6,670,369 | Use of phanquinone for the treatment of alzheimer's disease Formerly held Lapsed on the fee record Ended Dec 30, 2011 · USPTO record | Lapsed on the fee record | Ended Dec 30, 2011 | USPTO record |
| US 6,548,554 | Ionic aqueous composition containing levomenthol Lapsed on the fee record Ended Apr 15, 2011 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2011 | USPTO record |
| US 6,652,877 | Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias Formerly held Surrendered on reissue Surrendered on reissue Apr 11, 2006 · USPTO record | Surrendered on reissue | Surrendered on reissue Apr 11, 2006 | USPTO record |
| US 5,980,914 | Clioquinol for the treatment of Parkinson's disease Formerly held Term ended Term ended no later than Nov 9, 2019 · Low confidence | Term ended | Term ended no later than Nov 9, 2019 | Low confidence |
| US 5,994,323 | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof Formerly held Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |
| US 6,001,852 | Clioquinol for the treatment of Alzheimer's disease Formerly held Term ended Term ended no later than Dec 14, 2019 · Low confidence | Term ended | Term ended no later than Dec 14, 2019 | Low confidence |